In a bid to combat malaria with vaccines, Pune-based Gennova Biopharmaceuticals has tied up with Tulane University School of Public Health and Tropical Medicine to produce a vaccine to block transmission of malarial parasite from mosquitoes to humans.
Sanjay Singh, CEO of Gennova Pharmaceuticals, said the project is part of PATH Malaria Vaccine Initiative (MVI), a global programme set up with a